LifeCell Corporation and American Academy of Facial Plastic and Reconstructive Surgery Commit to Help Heal the Scars of Domestic Violence.

Business Editors & Health/Medical Writers

BRANCHBURG, N.J.--(BW HealthWire)--Nov. 9, 2000

As a further commitment to help survivors of domestic assault heal both the physical and emotional scars of abuse, LifeCell Corporation (Nasdaq:LIFC) is proud to be the major sponsor of the annual "Paint the Town" event to be held in New York City, Nov. 9, 2000. Hosted by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), this gala event was designed to raise funds to benefit one of the Academy's pro-bono programs called FACE TO FACE: The National Domestic Violence Project.

"We are proud to be associated with the FACE TO FACE program and look forward to contributing to the important work that the AAFPRS is accomplishing in the care of victims of domestic assault," said Paul Thomas, chairman and CEO of LifeCell Corporation.

FACE TO FACE: The National Domestic Violence Project was developed in 1994 through a partnership between AAFPRS and the National Coalition Against Domestic Violence (NCADV) to provide complimentary facial reconstructive and plastic surgery to survivors of domestic violence who have suffered facial, head and neck injuries, but cannot afford reconstructive treatment.

"We are extremely grateful to LifeCell Corporation for their generosity and commitment to the FACE TO FACE program," says AAFPRS President Russell W.H. Kridel, M.D. "Through this effort, patients benefiting from the surgical expertise of AAFPRS members can also take advantage of one of the most advanced technologies in plastic and reconstructive surgery."

In addition to being the major sponsor, LifeCell Corporation will provide AlloDerm and Cymetra free of charge to beneficiaries of the FACE TO FACE program whose procedures are deemed medically appropriate for AlloDerm and Cymetra use.

AlloDerm's primary applications include dermal grafts for full-thickness burn injuries, periodontal and gingival grafts, and dermal implants for reconstructive procedures. Specifically, in cases of facial damage due to domestic assault, the most common uses for AlloDerm and Cymetra include soft tissue reconstruction of the nose and eye areas.

About LifeCell Corporation

LifeCell Corporation develops and markets biologic solutions for the repair and preservation of human tissue. Our core technology removes all cells from the tissue and preserves it without damaging the essential biochemical and structural components necessary for normal tissue regeneration.

We currently market three products based on this technology: AlloDerm, for plastic reconstructive, burn, and dental markets; Cymetra, an injectable form of AlloDerm, for plastic reconstructive and dermatology markets; and Repliform, for urology and gynecology markets. The company's product development programs include small diameter blood vessel grafts produced as an alternative to blood vessel grafts taken from the patient and formulations for the extended storage of human blood cells, including additive solutions for red blood cells and Thrombosol for platelets.

More information about AlloDerm is available through the LifeCell Web site at www.lifecell.com. Consumers interested in receiving more information about FACE TO FACE: The National Domestic Violence Project can call 800/842-4546.